Evotec SE ( EVO) - Key Metrics
EVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.96 | -$0.24 | $0.15 | $0.02 |
| 2025Q1 | $1.13 | -$0.18 | -$0.18 | -$0.30 |
EVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -7.35 |
| 2025Q1 | ? | -8.52 |
EVO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.83% | ? |
| 2025Q4 | 5.00% | ? |
| 2025Q3 | -7.99% | ? |
| 2025Q2 | 0.21% | ? |
| 2025Q1 | -4.90% | ? |
EVO
Price: $2.80
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Germany
Volume: 14985
Market Capitalization: 1.0 billion